
Hims & Hers Health (HIMS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
586.0M
Gross Profit
430.7M
73.50%
Operating Income
57.9M
9.88%
Net Income
49.5M
8.44%
EPS (Diluted)
$0.20
Balance Sheet Metrics
Total Assets
891.7M
Total Liabilities
342.4M
Shareholders Equity
549.3M
Debt to Equity
0.62
Cash Flow Metrics
Operating Cash Flow
122.7M
Free Cash Flow
50.1M
Revenue & Profitability Trend
Hims & Hers Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 1.5B | 872.0M | 526.9M | 271.9M | 148.8M |
Cost of Goods Sold | 303.4M | 157.1M | 118.2M | 67.4M | 39.3M |
Gross Profit | 1.2B | 714.9M | 408.7M | 204.5M | 109.4M |
Gross Margin % | 79.5% | 82.0% | 77.6% | 75.2% | 73.6% |
Operating Expenses | |||||
Research & Development | 78.8M | 48.2M | 29.2M | 22.4M | 11.2M |
Selling, General & Administrative | 846.6M | 576.3M | 370.8M | 249.6M | 113.4M |
Other Operating Expenses | 185.8M | 119.9M | 77.4M | 47.6M | - |
Total Operating Expenses | 1.1B | 744.4M | 477.4M | 319.5M | 124.6M |
Operating Income | 61.9M | -29.5M | -68.7M | -115.0M | -15.1M |
Operating Margin % | 4.2% | -3.4% | -13.0% | -42.3% | -10.2% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | - | 0 | 10.0K |
Other Non-Operating Income | 9.8M | 7.9M | 3.0M | 4.2M | -2.8M |
Pre-tax Income | 71.7M | -21.6M | -65.7M | -110.8M | -18.0M |
Income Tax | -54.3M | 2.0M | -31.0K | -3.1M | 127.0K |
Effective Tax Rate % | -75.8% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 126.0M | -23.5M | -65.7M | -107.7M | -18.1M |
Net Margin % | 8.5% | -2.7% | -12.5% | -39.6% | -12.2% |
Key Metrics | |||||
EBITDA | 79.0M | -19.9M | -61.2M | -111.0M | -11.0M |
EPS (Basic) | $0.58 | $-0.11 | $-0.32 | $-0.58 | $-0.51 |
EPS (Diluted) | $0.53 | $-0.11 | $-0.32 | $-0.58 | $-0.51 |
Basic Shares Outstanding | 215939037 | 209344712 | 204516120 | 186781537 | 35353809 |
Diluted Shares Outstanding | 215939037 | 209344712 | 204516120 | 186781537 | 35353809 |
Income Statement Trend
Hims & Hers Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 220.6M | 96.7M | 46.8M | 71.8M | 27.3M |
Short-term Investments | 79.7M | 124.3M | 132.9M | 175.5M | 72.9M |
Accounts Receivable | 6.1M | 5.7M | 3.2M | 3.6M | 750.0K |
Inventory | 64.4M | 22.5M | 21.6M | 13.6M | 3.5M |
Other Current Assets | 8.9M | 5.2M | 1.8M | 890.0K | 2.0M |
Total Current Assets | 395.8M | 265.1M | 216.6M | 269.9M | 113.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 44.6M | 24.5M | 6.6M | 5.1M | - |
Goodwill | 268.9M | 240.3M | 243.6M | 247.7M | 59.0K |
Intangible Assets | 43.4M | 18.6M | 21.8M | 25.9M | 59.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 62.6M | 947.0K | 889.0K | 8.8M | 5.6M |
Total Non-Current Assets | 311.7M | 176.1M | 149.7M | 150.7M | 5.6M |
Total Assets | 707.5M | 441.2M | 366.3M | 420.6M | 118.7M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 91.2M | 43.1M | 32.4M | 19.6M | 8.1M |
Short-term Debt | 1.9M | 1.3M | 1.7M | 1.4M | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | 1.6M |
Total Current Liabilities | 221.4M | 88.5M | 47.9M | 79.2M | 15.2M |
Non-Current Liabilities | |||||
Long-term Debt | 9.5M | 8.7M | 3.6M | 4.1M | 0 |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | 22.0K | 3.0M | 2.6M | 381.0K |
Total Non-Current Liabilities | 9.5M | 8.7M | 6.7M | 6.7M | 250.3M |
Total Liabilities | 230.8M | 97.2M | 54.6M | 86.0M | 265.6M |
Equity | |||||
Common Stock | 22.0K | 21.0K | 21.0K | 20.0K | 5.0K |
Retained Earnings | -242.1M | -368.2M | -344.6M | -279.0M | -171.3M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 476.7M | 344.0M | 311.7M | 334.6M | -146.9M |
Key Metrics | |||||
Total Debt | 11.3M | 9.9M | 5.3M | 5.5M | 0 |
Working Capital | 174.5M | 176.6M | 168.7M | 190.7M | 97.9M |
Balance Sheet Composition
Hims & Hers Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 126.0M | -23.5M | -65.7M | -107.7M | -18.1M |
Depreciation & Amortization | 17.1M | 9.5M | 7.5M | 4.1M | 1.1M |
Stock-Based Compensation | 92.3M | 66.1M | 42.8M | 67.2M | 5.8M |
Working Capital Changes | 67.2M | 10.7M | 1.4M | 58.0K | 2.4M |
Operating Cash Flow | 243.9M | 68.6M | -12.2M | -40.1M | -4.6M |
Investing Activities | |||||
Capital Expenditures | -41.7M | -17.2M | -2.7M | -832.0K | -1.7M |
Acquisitions | -15.4M | 0 | -459.0K | -46.5M | 0 |
Investment Purchases | -160.6M | -157.2M | -187.7M | -266.6M | -95.0M |
Investment Sales | 209.7M | 171.6M | 230.1M | 161.8M | 59.5M |
Investing Cash Flow | -8.0M | -2.8M | 39.2M | -152.1M | -37.2M |
Financing Activities | |||||
Share Repurchases | -83.0M | -2.0M | 0 | -22.0M | 0 |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | 0 | 0 | 1.2M | 0 |
Debt Repayment | - | - | 0 | 0 | -1.5M |
Financing Cash Flow | -138.7M | -16.1M | -36.6M | 233.0M | 47.0M |
Free Cash Flow | 198.3M | 47.0M | -33.8M | -39.4M | -6.7M |
Net Change in Cash | 97.2M | 49.7M | -9.5M | 40.8M | 5.2M |
Cash Flow Trend
Hims & Hers Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
65.75
Forward P/E
112.91
Price to Book
20.84
Price to Sales
5.83
PEG Ratio
112.91
Profitability Ratios
Profit Margin
9.61%
Operating Margin
4.91%
Return on Equity
41.88%
Return on Assets
6.94%
Financial Health
Current Ratio
4.98
Debt to Equity
185.60
Beta
2.09
Per Share Data
EPS (TTM)
$0.79
Book Value per Share
$2.49
Revenue per Share
$9.13
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
hims | 11.7B | 65.75 | 20.84 | 41.88% | 9.61% | 185.60 |
Procter & Gamble | 359.9B | 23.60 | 7.02 | 31.24% | 18.95% | 69.86 |
Colgate-Palmolive | 68.4B | 23.79 | 97.46 | 398.04% | 14.54% | 832.51 |
Kimberly-Clark | 47.7B | 19.60 | 43.35 | 207.06% | 12.48% | 595.10 |
Kenvue | 41.0B | 28.45 | 4.07 | 10.65% | 9.37% | 88.04 |
Estee Lauder | 31.6B | 124.05 | 7.26 | -15.98% | -5.89% | 215.93 |
Financial data is updated regularly. All figures are in the company's reporting currency.